Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)

Authors

Kathryn Fletcher (ORCID: https://orcid.org/0000-0002-8423-8651)
Brendan Clifford (ORCID: https://orcid.org/0000-0002-9178-9013)
Nadine Ezard (ORCID: https://orcid.org/0000-0002-7495-8305)
Gillinder Bedi (ORCID: https://orcid.org/0000-0002-6718-0099)
Krista J. Siefried (ORCID: https://orcid.org/0000-0002-6534-3325)
Alexandre A. Guerin (ORCID: https://orcid.org/0000-0003-3833-3620)
Elizabeth Knock
Michael Millard (ORCID: https://orcid.org/0000-0002-0228-9560)
Celia J. A. Morgan (ORCID: https://orcid.org/0000-0002-8858-4906)
Liam Acheson (ORCID: https://orcid.org/0000-0002-2343-5504)
Robert May
Jonathan Brett (ORCID: https://orcid.org/0000-0003-3065-7495)
Hope Macdonald
Jess Doumany

Institutions

The University of Melbourne (AU)
University of Exeter (GB)
Alcohol and Drug Foundation (AU)
UNSW Sydney (AU)
St Vincent's Hospital Sydney (AU)
St Vincent's Health (AU)
Orygen (AU)
St Vincent's Clinic (AU)
National Centre for Clinical Research on Emerging Drugs (AU)
Imperial College London (GB)

Publication Details

Journal: BMJ Open
Published: 2025-02-01
DOI: https://doi.org/10.1136/bmjopen-2024-092504
Primary Topic: Treatment of Major Depression
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Department of Health and Aged Care, Australian Government
Medical Research Council
National Health and Medical Research Council

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)

Kathryn Fletcher, Brendan Clifford, Nadine Ezard, Gillinder Bedi et al.

Feb 1, 2025

BMJ Open

Treatment of Major Depression

article

Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)

Kathryn Fletcher, Brendan Clifford, Nadine Ezard, Gillinder Bedi, Krista J. Siefried, Alexandre A. Guerin, Elizabeth Knock, Michael Millard, Celia J. A. Morgan, Liam Acheson, Robert May, Jonathan Brett, Hope Macdonald, Jess Doumany

February 1, 2025article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(2)

The University of Melbourne (AU), University of Exeter (GB), Alcohol and Drug Foundation (AU), UNSW Sydney (AU), St Vincent's Hospital Sydney (AU), St Vincent's Health (AU), Orygen (AU), St Vincent's Clinic (AU), National Centre for Clinical Research on Emerging Drugs (AU), Imperial College London (GB)

Department of Health and Aged Care, Australian Government, Medical Research Council, National Health and Medical Research Council

Good health and well-being

Openalex Percentile: Top 97%

Treatment of Major Depression

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.